Imciromab pentetate Product Approval Information - Licensing Action

Proper name: Imciromab pentetate
Tradename: Myoscint
Manufacturer: Centocor B.V., Leiden, The Netherlands, License #1178
Indication for Use: Preparation of Indium In 111 Imciromab pentetate to be used as a cardiac imaging agent for detecting the presence and/or identifying the location of myocardial injury in patients with suspected myocardial infarction
Approval Date: 7/3/96
Type of submission: Biologics license application


Summary Basis for Approval (PDF)

Labeling (PDF)

Page Last Updated: 04/01/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English